Page last updated: 2024-08-21

oxazoles and baricitinib

oxazoles has been researched along with baricitinib in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	2 (100.00)	2.80

Authors

Authors	Studies
Cui, YM; Payne, CD; Sheng, XY; Wang, F; Zhang, X; Zhao, X	1
Chen, J; Cheng, Q; Fang, Z; Jia, Q; Zhao, G	1

Reviews

1 review(s) available for oxazoles and baricitinib

Article	Year
Efficacy and safety of current medications for treating severe and non-severe COVID-19 patients: an updated network meta-analysis of randomized placebo-controlled trials. Aging, 2021, 09-16, Volume: 13, Issue:18 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azetidines; COVID-19; COVID-19 Drug Treatment; Humans; Imatinib Mesylate; Immunologic Factors; Network Meta-Analysis; Oxazoles; Purines; Pyrazoles; SARS-CoV-2; Severity of Illness Index; Sulfonamides; Thiohydantoins; Treatment Outcome	2021

Article

Year

Efficacy and safety of current medications for treating severe and non-severe COVID-19 patients: an updated network meta-analysis of randomized placebo-controlled trials.

Aging, 2021, 09-16, Volume: 13, Issue:18

Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azetidines; COVID-19; COVID-19 Drug Treatment; Humans; Imatinib Mesylate; Immunologic Factors; Network Meta-Analysis; Oxazoles; Purines; Pyrazoles; SARS-CoV-2; Severity of Illness Index; Sulfonamides; Thiohydantoins; Treatment Outcome

2021

Trials

1 trial(s) available for oxazoles and baricitinib

Article	Year
Pharmacokinetics, Safety, and Tolerability of Single- and Multiple-Dose Once-Daily Baricitinib in Healthy Chinese Subjects: A Randomized Placebo-Controlled Study. Clinical pharmacology in drug development, 2020, Volume: 9, Issue:8 Topics: Administration, Oral; Adult; Area Under Curve; Arthritis, Rheumatoid; Asian People; Azetidines; Case-Control Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Tolerance; Female; Half-Life; Healthy Volunteers; Humans; Male; Middle Aged; Oxazoles; Placebos; Purines; Pyrazoles; Safety; Sulfonamides	2020

Article

Year

Pharmacokinetics, Safety, and Tolerability of Single- and Multiple-Dose Once-Daily Baricitinib in Healthy Chinese Subjects: A Randomized Placebo-Controlled Study.

Clinical pharmacology in drug development, 2020, Volume: 9, Issue:8

Topics: Administration, Oral; Adult; Area Under Curve; Arthritis, Rheumatoid; Asian People; Azetidines; Case-Control Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Tolerance; Female; Half-Life; Healthy Volunteers; Humans; Male; Middle Aged; Oxazoles; Placebos; Purines; Pyrazoles; Safety; Sulfonamides

2020